These findings suggest that semaglutide in human milk is unlikely to pose significant risks to breastfed children
First, Wegovy is FDA-approved for weight loss, ensuring it has undergone rigorous testing for safety, efficacy, and consistent quality
#CardiovascularCare #PharmaInnovation #Repatha #HeartHealth #ClinicalResearch To view or add a comment, sign in A new study presented at the European Society of Cardiology Congress 2025, powered by Truveta Data from more than 200,000 patients, found: Early discontinuation was linked to higher cardiovascular risks
Manufacturer savings programs and coupons may help reduce the monthly cost
12 Commonly, patients may experience gastrointestinal disturbances such as nausea, vomiting, diarrhea, and constipation
Unregulated GLP-1 Patches Despite the scientific challenges, GLP-1 patches are being sold online and in beauty clinics as cosmetic or detox products